Background
Worldwide, work participation of cancer survivors has seen a surge of attention in the last two of decades [
1]. A cancer diagnosis can be a devastating and, often,life-threatening experience [
2], which frequently results in short- or long-term disability [
3‐
6] due to both health and economic burdens [
7]. Cancer imposes a substantial burden in terms of reducing the autonomy of individuals to perform their general daily activities [
1,
8]. Furthermore, a cancer diagnosis negatively affects employment status in terms of job opportunities, work participation and work ability due to the illness [
1,
8]. The adverse side-effects of treatment results in physical and psychological limitations that can be a barrier to work participation [
9]. However, the burden of physical disability levels varies by cancer stages and types [
10]. Cancer survivors run a significantly high risk of unemployment and early retirement, and they have less opportunity to be re-employed [
1]. A cohort study showed that 20% of cancer survivors reported disabilities due to cancer over a 5 year follow-up period [
11]. An estimated 30% of cancer survivors reported work disabilities post-treatment [
12]. However, a prospective cohort study confirmed that the employment opportunities of cancer survivors were adversely impacted by their recovery and health status [
13]. Return to work participation may assist cancer survivors to recover faster, improve their quality of life, help return them to their former ‘normal’ life, increase their self-confidence, and may support them to overcome the negative side-effects of treatment [
14,
15]. Furthermore, improvement of work participation of cancer survivors contributes to societal benefit, by reducing absenteeism, and reducing disability benefit payments and productivity losses [
16]. Notably, cancer survivors’ earnings are 10% lower compared to non-cancer survivors [
17]. Therefore, there is a greater need to provide supportive services (e.g., related to rehabilitation) to both help cancer survivors adapt to disability, and prevent work disability in this patient population.
In Australia, the incidence of cancer in individuals results in different disability levels for cancer survivors [
2]. The long-term effects of cancer treatment are a significant cause of greater absenteeism, higher unemployment and early retirement [
18], and overall reduced participation in work [
2‐
6]. Approximately 40% of Australian cancer patients are of working age [
19], with 46% being unable to return to employment after a cancer diagnosis [
20], and 67% changing their employment status following diagnosed [
21]. This results in a reduction of $1.7 billion to Australian gross domestic product (GDP) annually [
20]. The impact of work disability constitute a substantial burden for people who have not had an occupation due to cancer, as well as to their families and employers. Furthermore, cancer-related treatment results in patients experiencing economic burden due to high out-of-pocket expenses (e.g., medicines and advanced treatments, including diagnostics), lost productivity, loss/reduction of household income, and other induced expenditure [
22]. The majority of cancer patients depend on family, relatives and friends for physical and economic support during their course of treatment and in the last stages of the disease [
23,
24]. Ultimately, cancer survivors are faced with a double burden in terms of their health and economic situation.
Existing studies have focused on cancer survivors’ characteristics and work participation, including in the United States [
1,
10,
12,
16,
25‐
27], Canada [
3,
13], South Korea [
8], the Netherlands [
5,
6,
9], and Belgium [
4,
28]. A number of factors adversely influencing work participation of patients with cancer has been determined in different settings. These parameters are associated with patients’ socio-demographic characteristics (e.g., age, educational status and economic position) [
5,
6,
9,
27], disease-related factors (e.g., tumor site, advanced tumor stage), advanced course of treatment (e.g., chemotherapy) [
3,
6,
7,
27], and work-related factors (e.g., physical work demands) [
1,
9]. The presence of comorbid conditions in cancer patients creates a higher likelihood of work-related disability [
3]. That is, cancer survivors with poor health status were significantly correlated with a higher level of work disability [
27]. A study conducted in the Netherlands found that cancer survivors who had experienced hormone therapy, metastatic disease, had limited physical strength, and limited workability, were strongly and adversely associated with a higher risk of work disability [
5,
6]. The poor perceptions of cancer survivors, in terms of their health and work ability [
6], their unhealthy behaviours (e.g., alcohol consumption), and their clinical stage [
29] were also significant predictors in determining independent effects of their work disability levels.
In Australia, studies have been conducted among cancer patients exploring the psychological effects of current treatment or level of disability [
30], association with work-related stress and cancer [
31], and lost productivity due to cancer [
20]. However, very limited evidence exists of the health burden in relation to work disability of cancer survivors in Australia. That is, potential factors associated with work disability of cancer survivors are poorly explored. This may be partially accounted for by various study designs, analytical rigour and follow-up periods. For instance, many international studies have used a limited number of predictors. The majority of the previous studies have been cross-sectional in nature, in terms of clinical and treatment perspectives. Thus, a comprehensive study is important to examine the impact of the health burden in relation to the magnitude of work disability as a long-term sequela of patients with cancer. There has been a recent surge of attention in the field of cancer survivorship, leading to efforts to identify and manage treatment-related sequelae, enhance quality of life, and improve the overall functioning of people who are receiving long-term follow-up care after cancer treatment.
Using longitudinal data from nationally representative Australian samples, these findings will help to improve the understanding of potential employment opportunities after a cancer diagnosis. In addition, these findings may be considered from different perspectives in cancer policy discussions: the cancer survivor (e.g., health status, work disability level, return to employment); the caregiver and the family (e.g., the health burden, reduction of socio-economic position, risk of poverty); the employer and co-workers (e.g., employment conditions, workload); the health care provider (e.g., supportive care needs, effective programs and interventions); and the community or society (e.g., economic and policy changes).
The present study aims to examine the health burden impact on the magnitude of work disability of cancer survivors after controlling several factors (e.g., socioeconomic, lifestyle, healthcare utilisation, and geographical location) over an extended period of 2003–2017. To achieve the research aim, the following three research questions (RQ) were posed:
RQ-1: What is the magnitude of work disability levels among cancer patients in Australia?
RQ-2: What is the longitudinal association between health burden and the magnitude of work disability among cancer patients in Australia over 2003–2017?
RQ-3: What are the potential predictors associated with the magnitude of work disability for cancer patients in Australia over this extended period?
Discussion
Cancer is significantly correlated with workdays lost and high levels of work-related disability [
29,
38‐
40]. The main objectives of this study were to investigate the magnitude of work disability due to a cancer diagnosis and measure the longitudinal association between health burden and disability, and the potential predictors of work disability of cancer patients. The study results show that 50% of cancer patients experienced a long-term disability, whereas approximately 18% of patients had reached an extreme level of work disability. Furthermore, the prevalence of disability was pronounced in relation to the level of the cancer burden (e.g., 71% for severe burden, 45% for moderate burden, and 23% for no burden), aged patients (66%), and unemployed patients (65%), those engaged in limited physical activities (61%), the uninsured (59%), and the poorest socio-economic group (23%). Potential predictors, which included factors such as age, those who exercise less or not at all, those who have an extreme health burden, and engage in unhealthy behaviours (e.g., alcohol consumption), were significantly associated with a higher risk of having an extreme disability.
The results showed that a higher risk of a severe or moderate disability level was pronounced among cancer patients who faced an extreme health burden, compared with patients who reported an excellent health status. A previous study found that poor health status of cancer patients resulted in greater functional disability (e.g., specific task difficulties) [
41,
42]. However, the prevalence of long-term disability was more pronounced in combination with a cancer diagnosis [
5,
6,
12,
27,
29]. Advanced cancer treatments can damage healthy cells or organs [
43]. For example, radiation and chemotherapy may impose short and long-term health problems and impact on the spinal cord, nerves and brain, which then may significantly contribute to long-term adverse outcomes like work-related disability. In the context of Australia, a significant proportion (46%) of cancer patients are unable to return to employment after their diagnosis [
20].
Furthermore, work disability leads to a substantial economic burden on society, individuals and their families, resulting in a reduction of $1.7 billion annually to GDP in Australia [
20] and an approximately 5% GDP reduction in the Organisation for Economic Co-operation and Development (OECD) countries [
44]. Therefore, cancer survivors may require psycho-social healthcare services and other therapeutic modalities, such as physical and occupational therapy, to assist in their return to a productive work life. Cancer patients with physically demanding jobs may require assistance during treatment, and possibly physical rehabilitation following treatment, in order to minimize morbidity. However, developing new and improved treatments with fewer side effects is another potentially important strategy to reduce cancer-related disability.
The results indicate that elderly cancer patients (older than 65 years) were at a significantly higher risk of having an extreme disability compared with younger patients (< 25 years). This finding is consistent with a previous study, which revealed that elderly cancer patients reported significantly more functional disabilities [
45], required more assistance with daily living activities [
46], and had deficits in performing work-related activities in terms of their physical ability [
41,
47]. Thus, several factors might influence the reduction in their physical functioning. For example, a course of advanced cancer treatment is associated with considerable physical and psychological side effects in elderly cancer patients (e.g., weight change, muscle loss, fatigue and physical weakness) [
48], and having multiple comorbidities [
3,
27,
29] will presumably contribute to reduced daily activities. Moreover, an elderly cancer patient may have a limited acceptance of advanced treatment and health outcomes that may then contribute to a greater burden of health [
48]. This result indicates that rehabilitation-related interventions (e.g., occupational and physical therapies) are essential to prevent ongoing work disability of cancer patients [
49], and is an emerging cancer research area, particularly focused on the elderly [
50].
The study results found that low level or no physical activities in cancer patients was strongly associated with an extreme level of work-related disability compared with patients engaged in high-level physical activity. This finding is consistent with other research [
38,
51‐
54], whereby authors found that limited physical activity levels were significantly associated with a higher risk of work disability among cancer patients. Further, a number of previous studies have proven that physical activity plays an effective role in ensuring improved health status [
55], reducing the risk of developing future cancers [
54], and also expressively contributing to lower mortality risk [
56], which ultimately produces significant health benefits and reduces medical expenditures and treatment outcome disparities [
55]. In terms of cancer risk, high levels of physical activities (compared with low levels) played a significant role in prevention of several cancers (e.g., 42% for gastrointestinal cancer, 23% for renal cancer, and 20% for myeloid leukemia) [
57]. This included averting genetic damage, improving the immune system, reducing chronic infections, and controlling cancer cells [
57]. Several hypotheses and mechanisms have been suggested regarding the anti-cancer effects of physical activities. The American Cancer Society guidelines for cancer survivors [
58] recommend daily physical activities, including a continuation of normal daily life activities immediately after diagnosis, which help to significantly reduce physical stamina and muscle strength erosion as well as anxiety levels, thereby resulting in the prevention of long-term adverse health outcomes (e.g., work-related disability) [
59].
This study results found an increased risk of work disability among cancer patients who consumed alcohol compared with patients who did not. In this study, alcohol consumption had a robust effect on patient outcomes. Formal drinkers represented two-thirds (≈ 75%) of the cohort and had a 46% greater risk of disability. The last Global Burden of Disease study, conducted in 2016, found a similar result, namely that alcohol consumption was a dominating determinant for higher risk of having a disability [
60]. The World Health Organisation (WHO) has suggested that harmful alcohol consumption causes a high burden of disease, including cancer [
61], which is often underappreciated [
60]. This finding has further implications for the reform of public health policy, and decreasing population-level alcohol consumption should be recommended.
The risks of having an extreme disability level amongst cancer patients who lived in the poorest households were more pronounced compared with their richer counterparts. Recent studies have confirmed this result with disadvantaged socio-economic status of cancer survivors being negatively associated with long-term health effects or work-related disability [
62,
63]. Some studies have also provided evidence that the magnitude of the cancer burden is negatively associated with socio-economic status [
16,
31‐
34]. Furthermore, adverse health outcomes (e.g., worse health status, long and short-term disability and shorter life expectancy) were disproportionately found in poorer people as opposed to those with higher socio-economic status [
13,
16,
31,
33,
64‐
71]. Contribtuing factors to the high rates of long term health impacts among the poorest groups includes higher tobacco rates [
16,
27], economic burden [
35,
36], increased mental illness [
72], lack of health education and awareness [
73], and less access to competent and effective health care services [
73].
Low productivity, loss/reduction of household income, and increased healthcare expenditure are pronounced amongst the poorest cancer patients. Growing socio-economic inequalities of cancer outcomes need the attention of governments, health systems and decision makers. For example, Cancer Australia has an optimal care pathway project, which has already addressed several cancer types. Such initiatives might help to reduce socio-economic inequalities, which are related to poverty, gender, education, and health, and should promote universal access to health care which can further enhance both socio-economic and human development.
The ability to continue in the labour force, and allowing an individual the choice to do so, signifies a key aspect of the health status often threatened by disease. Long-term disability threatens the economic well-being of survivors and their families. Additionally, the health status of cancer patients who are restricted in their capacity to work may be affected by the loss of identity, life satisfaction, and social relationships that work often provides. Cancer survivorship, work disability and employment may be considered from different perspectives: the cancer survivor (e.g., health status, work disability level and return to employment), the caregiver and the family (e.g., the health burden, reduction of socioeconomic position and risk for poverty), the employer and co-workers (e.g., employment conditions and workload), the health care provider (e.g., supportive care needs, effective programs and interventions), and the community or society (e.g., economic and policy changes).
This study includes some caveats. Study participants were accessed from the HILDA survey, which covers health, economic, employment, income and health characteristics of household members aged 15 years and older. Children who suffered from cancer were excluded from this study. Examining the long-term work disability is widely perceived to have substantial potential as an endpoint in health outcomes research; however, results are partially dependent upon study methods and outcome variables of interest. The participants of the present study were derived from the protocol “HILDA study” [
32], wherein long-terms health conditions of cancer patients might change for independent study designs as well as application of survey instruments.
This study findings established a relationship between overall cancer burden and work-related disability among cancer survivors, which might vary in terms of cancer stages and types of cancer. The authors were not able to estimate the cancer-specific health burden nor the work disability of cancer survivors due to the paucity of relevant data. Further, the study findings were based on self-reported responses that might have been impacted by respondents’ prejudice (e.g., silence and over-response), and by problems in understanding and interpreting the survey questions.
Despite these limitations, this study has noteworthy strengths including the use of a prospective design of long term follow-ups, and the application of well-validated and reliable longitudinal wave measures of the impacts of cancer diagnosis on the health burden and work disability of individuals over the 2003–2017 period. The study population was ethnically, geographically, and socio-economically diverse. Furthermore, this study included several potential confounding analytical factors that were not present in previous studies. For this study, data were gathered from five-waves of the HILDA survey of cancer survivors. The length of the survey period may have introduced uncontrolled bias, as changes in health status are not instantaneous and might emerge only after time, which was not captured in this study. Due to funding restrictions, the authors were unable to consider cancer patients who registered for cancer surveillance as well as received health care from health facilities (e.g., private clinics, community clinics, secondary or tertiary hospitals). Due to the paucity of cancer-related data in HILDA study, the authors were unable to perform cancer-specific analysis and period of treatment analysis. Future research is required using a similar study design, perspective and analytical methods in terms of cancer-specific exploration.